Synlogic (SYBX) Investor Presentation - Slideshow

Exploratory Preclinical Phenylketonuria (PKU) RPDD FT ODD SYNB8802 SYNB2081 Inflammatory Bowel Disease (IBD) © 2023 SYNLOGIC. CORPORATE PRESENTATION. ALL RIGHTS RESERVED. | 7 Advanced Clinical Programs with Strong Commercial Potential 1. Assumes indicated for pediatric through adult 2. Assumes indicated for pediatric through adult 3. Assumes market of adults with highly recurrent stones due to enteric hyperoxaluria SYNB1934 for Phenylketonuria (PKU) PKU: Unique Opportunity for Value Creation * First generat ...